Alivus Life Sciences to review financial results at board meeting October 29, 2026 Back
<p>Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, will hold a board meeting on Thursday, October 29, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, and has closed the trading window for its designated persons from October 1, 2026, to October 31, 2026, in accordance with SEBI regulations.</p>